- 兒科治療藥物的安全應用
- 李德愛 陳志紅 傅平主編
- 312字
- 2019-08-22 17:02:25
參考文獻
1.邵肖梅,葉鴻瑁,丘小汕.實用兒新生兒學.第4版.北京:人民衛生出版社,2011.
2.中華醫學會兒科學分會新生兒學組.新生兒黃疸診療原則的專家共識.中華兒科雜志,2010,48(9):685-696.
3.沈剛.新編實用兒科藥物手冊.第2版.北京:人民軍醫出版社,2009.
4.Perlman JM.Intervention strategies for neonatal hypoxic-ischemic cerebral injury.Clin Ther,2006,28:1353-1365.
5.Konduri GG,Kim UO.Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.Pediatr Clin North Am,2009,56:579-600.
6.Gras L,Wallon M,Pollak A,et al.Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy:A cohort study in European centres.Acta Paediatr,2005,94:1721-1731.
7.Kattwinkel J,Bloom BT,Delmore P,et al.High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome.Pediatrics,2000,106:282-288.
8.Alfaleh K,Smyth JA,Roberts Rs,et al.Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely low birth weight infants:results from the trials of indomethacin in prophylaxis in preterms.Pediatrics,2008,121:233-238.
9.Ostrea EM,Villanueva-Uy ET,Natarajan G,et al.Persistent pulmonary hypertension of the newborn with transposition of the treat arteries:successful treatment with bosentan.Eur J Pediatr,2008,167:437-440.